Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study

Psychosomatic Medicine

Volumn 66, Issue 4, 2004, Pages 466-474

  Carney, Robert M ^a   Blumenthal, James A ^b   Freedland, Kenneth E ^a   Youngblood, Marston ^c   Veith, Richard C ^d   Burg, Matthew M ^e   Cornell, Carol ^f   Saab, Patrice G ^g   Kaufmann, Peter G ^h   Czajkowski, Susan M ^h   Jaffe, Allan S ⁱ  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c University of North Carolina at Chapel Hill   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^h Natl Heart Lung/Blood Institute   (United States)

ⁱ MAYO CLINIC   (United States)

Author keywords

Cognitive therapy; Depression; Depressive disorder; Mortality; Myocardial infarction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SERTRALINE;

ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DEPRESSION; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MORTALITY; MULTICENTER STUDY; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZATION; SCORING SYSTEM; SOCIAL SUPPORT; SURVIVAL; TREATMENT OUTCOME;

COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERSONALITY INVENTORY; PROPORTIONAL HAZARDS MODELS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SOCIAL SUPPORT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 3242803517     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000133362.75075.a6     Document Type: Article

References (27)

1. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6 month survival. JAMA 1993;270:1819-25.
2. Ahern DK, Gorkin L, Anderson JL, Tierney C, Ewart C, Capone RJ, Schron E, Kornfeld D, Herd JA, Richardson DW, Follick MJ. Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol 1990;66:59-62.
3. Ladwig KH, Kieser M, Konig J, Breithardt G, Borggrefe M. Affective disorders and survival after acute myocardial infarction. Eur Heart J 1991;12:959-64.
4. Kaufmann MW, Fitzgibbons JP, Sussman EJ, Reed JF, Einfalt JM, Rodgers JI, Fricchione GL. Relation between myocardial infarction, depression, hostility, and death. Am Heart J 1999;138:549-54.
5. Denollet J, Sys SU, Brutsaert DL. Personality and mortality after myocardial infarction. Psychosom Med 1995;57:582-91.
6. Bush DE, Ziegelstein RC, Tayback M, Richter D, Stevens S, Zahalsky H, Fauerbach JA. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001;88:337-41.
7. Irvine J, Basinski A, Baker B, Jandciu S, Paquette M, Cairns J, Connolly S, Roberts R, Gent M, Dorian P. Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Psychosom Med 1999;61:729-37.
8. The ENRICHD Investigators. Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD): study design and methods. Am Heart J 2000;139:1-9.
9. The ENRICHD Investigators. Effects of treating depression and low perceived social support on clinical events after a myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA 2003;289:3106-16.
10. Boland RJ, Keller MB. Course and outcome of depression. In: IH Gotlib, CL Hammen, editors. Handbook of Depression. New York: The Guilford Press; 2002.
11. Hance M, Carney RM, Freedland KE, Skala J. Depression in patients with coronary heart disease: A 12 month follow up. Gen Hosp Psychiatry 1996:18;61-5.
12. Freedland KE, Skala JA, Carney RM, Raczynski JM, Taylor CB, Mendes de Leon CF, Ironson G, Youngblood ME, Krishnan KRR, Veith RC, for the ENRICHD Investigators. The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosom Med 2002;64:897-905.
13. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York: Guilford Press; 1979.
14. Beck JS. Cognitive Therapy: Basics and Beyond. New York: Guilford Press; 1995.
15. The ENRICHD Investigators. Enhancing recovery in coronary heart disease patients (ENRICHD): study intervention. Psychosom Med 2001;63:747-55.
16. Cox DR. Regression models and life tables. J Royal Stat Soc Series B 1972;34:187-220.
17. Jaffe A, Blumenthal J, Bittner V, O'Connor C, Calvin J, Catellier D, Hosking J, Freedland K, Krumholz H, Norman J, Rich M, Sheps D, Sequeria R, Wu C. Baseline medical outcome predictors of the ENRICHD study.
18. Everson SA, Goldberg DE, Kaplan GA, Cohen RD, Pukkala E, Tuomilehto J, Salonen JT. Hopelessness and risk for mortality and the incidence of myocardial infarction and cancer. Psychosom Med 1996;58:113-21.
19. Krishnan KR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry 1997;154:497-501.
20. Meltzer HY, Maes M, Elkis H. The biological basis of refractory depression. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD, editors. Refractory Depression: Current Strategies and Future Directions. New York: John Wiley & Sons; 1994.
21. Amsterdam J, Mosley PD, Rosenzweig M. Assessment of adrenocortical activity in refractory depression: steroid suppression with ketoconazole. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD, editors. Refractory Depression: Current Strategies and Future Directions. Chichester, UK: John Wiley & Sons; 1994:199-210.
22. Targum SD. The application of serial neuro-endocrine challenge studies in the management of depressive disorder. Biol Psychiatry 1983;18:3-19.
23. Christiansen P, Lolk A, Gram LF. Cortisol and treatment of depression: predictive value of spontaneous and suppressed cortisol levels and course of spontaneous plasma cortisol. Psychopharmacology 1989;97:471-5.
24. Sluzewska A, Rybakowski JK, Sobieska M, Bosmans E, Pollet H, Wiktorowicz K. Increased levels of alpha-1-acid glycoprotein and interleukin-6 in refractory depression. Depression 1995;3:170-5.
25. Vedder H, Lanquillon S, Krieg JC. Cytokine secretion and treatment response in major depression. Biol Psychiatry 2000;47:89S.
26. Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T. Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry 1997;154:426-8.
27. Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 2002;53:897-902.